ClinicalTrials.Veeva

Menu

Prospective Study of the Impact of Systemic Corticosteroid Use on Measures of Sleep Disordered Breathing

R

Rambam Health Care Campus

Status

Completed

Conditions

Sleep Apnea

Treatments

Other: sleep study

Study type

Observational

Funder types

Other

Identifiers

NCT01228695
IRB2421CTIL

Details and patient eligibility

About

Weight gain is both a significant risk factor for obstructive sleep apnea and a side-effect of long-term systemic steroids therapy.

This study aimed to investigate the impact of long-term systemic steroid treatment on sleep apnea.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • For inclusion, a scheduled therapy with a minimum daily dose of 10 mg prednisone (or equivalent) for at least 3 months was required

Exclusion criteria

  • Patients younger than 18 years and those with known sleep apnea or other forms of sleep-disordered breathing were excluded

Trial design

20 participants in 1 patient group

steroid treatment
Treatment:
Other: sleep study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems